Evidence map›Paper›PMID 26985903›Full record

ArticleViruses2016

Long Terminal Repeat Circular DNA as Markers of Active Viral Replication of Human T Lymphotropic Virus-1 in Vivo.

James M Fox, Silva Hilburn, Maria-Antonietta Demontis, David W Brighty, Maria Fernanda Rios Grassi, Bernardo Galvão-Castro, Graham P Taylor, Fabiola Martin

Open access · goldAbstract read
In one paragraph

Article in Viruses, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 16 citations in OpenAlex.

  1. Clinical trial of raltegravir, an integrase inhibitor, in HAM/TSP.Annals of clinical and translational neurology · 2021
    Trial
  2. Article
  3. Review
  4. Review
  5. Frontiers in microbiology · 2022
    Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 2 countries.

James M FoxCentre for Immunology and Infection, Department of Biology & Hull York Medical School, University of York, York YO10 5DD, UK. james.fox@york.ac.uk.
Silva HilburnSection of Infectious Diseases, Department of Medicine, Imperial College, London W2 1PG, UK. s.hilburn@imperial.ac.uk.
Maria-Antonietta DemontisSection of Infectious Diseases, Department of Medicine, Imperial College, London W2 1PG, UK. m.demontis@imperial.ac.uk.
David W BrightyDivision of Cancer Research, Ninewells Hospital & Medical School, University of Dundee, Dundee DD1 9SY, UK. d.w.brighty@dundee.ac.uk.
Maria Fernanda Rios GrassiOswaldo Cruz Foundation, Gonçalo Moniz Research Center-BA, Advanced Laboratory of Public Health, Salvador, Bahia, Candeal 40296-710, Brazil. grassi@bahia.fiocruz.br.
Bernardo Galvão-CastroHTLV-Centre Bahian School of Medicine, Salvador, Bahia 40050-420, Brazil. galvao@bahiana.edu.br.
Graham P TaylorSection of Infectious Diseases, Department of Medicine, Imperial College, London W2 1PG, UK. g.p.taylor@imperial.ac.uk.
Fabiola MartinCentre for Immunology and Infection, Department of Biology & Hull York Medical School, University of York, York YO10 5DD, UK. fabiola.martin@hyms.ac.uk.
Imperial College Healthcare NHS Trust · GBUniversity of York · GBFundação Oswaldo Cruz · BRImperial College London · GBUniversity of Dundee · GB

Funding

Wellcome TrustWellcome Trust 092430/Z/10/Z
6 · The paper itself

Abstract

Clonal expansion of human T-lymphotropic virus type-1 (HTLV-1) infected cells in vivo is well documented. Unlike human immunodeficiency virus type 1 (HIV-1), HTLV-1 plasma RNA is sparse. The contribution of the "mitotic" spread of HTLV-1 compared with infectious spread of the virus to HTLV-1 viral burden in established infection is uncertain. Since extrachromosomal long terminal repeat (LTR) DNA circles are indicators of viral replication in HIV-1 carriers with undetectable plasma HIV RNA, we hypothesised that HTLV-1 LTR circles could indicate reverse transcriptase (RT) usage and infectious activity. 1LTR and 2LTR DNA circles were measured in HTLV-1 cell lines and peripheral blood mononuclear cells (PBMC) of asymptomatic carriers (ACs) and patients with HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) or adult T cell leukaemia/lymphoma (ATLL). 1LTR DNA circles were detected in 14/20 patients at a mean of 1.38/100 PBMC but did not differentiate disease status nor correlate with HTLV-1 DNA copies. 2LTR DNA circles were detected in 30/31 patients and at higher concentrations in patients with HTLV-1-associated diseases, independent of HTLV-1 DNA load. In an incident case the 2LTR DNA circle concentration increased 2.1 fold at the onset of HAM/TSP compared to baseline. Detectable and fluctuating levels of HTLV-1 DNA circles in patients indicate viral RT usage and virus replication. Our results indicate HTLV-1 viral replication capacity is maintained in chronic infection and may be associated with disease onset.

Indexed as

Terminal Repeat SequencesVirus ReplicationBiomarkersBloodCarrier StateCells, CulturedDNA, CircularFemaleHTLV-I InfectionsHumansHuman T-lymphotropic virus 1Leukocytes, MononuclearMaleRNA-Directed DNA PolymeraseBiomarkersDNA, CircularRNA-Directed DNA PolymeraseHTLVhuman T-lymphotropic viruslong terminal repeatLTR DNA circlesviral replication

Identifiers

PMID26985903
PMCPMC4810270
OpenAlexW2299576453

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.